Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 18.19
+0.64 (3.65%)
Aug 10, 2026, 3:00 PM CST
SHA:600521 Market Cap
SHA:600521 has a market cap or net worth of 27.11 billion as of August 10, 2026. Its market cap has decreased by -11.19% in one year.
Market Cap
27.11B
Enterprise Value
33.81B
Revenue
8.55B
Ranking
n/a
PE Ratio
73.12
Stock Price
18.19
ChartMarket Cap Chart
Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 27.11B, an increase of 582.67%. That is a compound annual growth rate of 8.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 27.11B | 7.19% |
| Dec 31, 2025 | 25.29B | -2.34% |
| Dec 31, 2024 | 25.89B | 19.93% |
| Dec 29, 2023 | 21.59B | -33.42% |
| Dec 30, 2022 | 32.43B | 0.57% |
| Dec 31, 2021 | 32.25B | -34.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Betta Pharmaceuticals | 29.54B |
| Humanwell Healthcare (Group) | 29.30B |
| Shijiazhuang Yiling Pharmaceutical | 28.39B |
| Apeloa Pharmaceutical Co.,Ltd | 26.36B |
| Dizal (Jiangsu) Pharmaceutical | 26.05B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.91B |
| Livzon Pharmaceutical Group | 24.87B |
| Guangdong Zhongsheng Pharmaceutical | 24.29B |